P179: Plasma cytokine and chemokine patterns during PEG‐IFNa‐2a therapy of chronic hepatitis delta

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|108-109

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 108-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between the IFNA1 (-2C→T) Polymorphism and Increased IFNAR1 Gene Expression Levels in Chronic Hepatitis B Infection

By  

Intervirology, Vol. 58, Iss. 6, 2016-04 ,pp. : 393-402

Karger

Access to resources Recommend Favorite

Usefulness of a New Immunoradiometric Assay of HCV Core Antigen to Predict Virological Response during PEG-IFN/RBV Combination Therapy for Chronic Hepatitis with High Viral Load of Serum HCV RNA Genotype 1b

By  

Intervirology, Vol. 51, Iss. 1, 2008-06 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Appearance of Oral Erosive Lichen Planus during Interferon Alfa‐2a Therapy for Chronic Active Hepatitis C

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 6, 1995-06 ,pp. : 461-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history

By Degasperi Elisabetta   Viganò Mauro   Aghemo Alessio   Lampertico Pietro   Colombo Massimo  

Expert Review of Anti-Infective Therapy, Vol. 11, Iss. 5, 2013-05 ,pp. : 459-474

Informa Healthcare

Access to resources Recommend Favorite

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 344-349

Karger

Access to resources Recommend Favorite